Clinical Trials Browser

Phase 2 × OTHER × navitoclax × Clear all

NCT02591095 2019-03-19

MONAVI-1

Phase 2 Completed

Ovarian Neoplasms

NCT01828476 2017-05-04

Navitoclax and Abiraterone Acetate With or Without Hydroxychloroquine in Treating Patients With Progressive Metastatic Castrate Refractory Prostate Cancer

Phase 2 Terminated

13 enrolled 5 charts

Prostatic Neoplasms